News AbbVie signs $2.9bn deal with I-Mab for ‘don’t eat me’ cance... AbbVie has claimed rights to an immuno-oncology antibody from I-Mab in what is thought to be a record licensing deal involving a Chinese biotech.
News ZS to acquire Trials.ai to deliver pharmaceuticals faster It has been announced that global management consulting and technology firm
News Welcome to the new pharmaphorum Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved